We are live on ! Find out more
TCM

Towercrest Capital Management Portfolio holdings

AUM $717M
1-Year Est. Return 15.39%
This Fund
S&P 500
This Quarter Est. Return
-12.63%
1 Year Est. Return
+15.39%
3 Year Est. Return
+39.13%
5 Year Est. Return
+30.16%
10 Year Est. Return
+92.7%
AUM
$333M
AUM Growth
-$58.3M
Cap. Flow
-$2.89M
Cap. Flow %
-0.87%
Top 10 Hldgs %
49.9%
Holding
87
New
8
Increased
31
Reduced
31
Closed
9

Sector Composition

Rank Sector Weight
1 Technology 1.77%
2 Financials 1.08%
3 Healthcare 1%
4 Communication Services 0.79%
5 Consumer Staples 0.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTI icon
76
Vanguard Morningstar Total Stock Market ETF
VTI
$681B
$210K 0.06%
1,283
VGT icon
77
Vanguard Information Technology ETF
VGT
$147B
$206K 0.06%
6,720
SPSB icon
78
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.7B
$201K 0.06%
+6,549
New +$200K
DIA icon
79
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$46.7B
-1,133
Closed -$324K
HD icon
80
Home Depot
HD
$352B
-1,705
Closed -$373K
MMM icon
81
3M
MMM
$93.9B
-1,948
Closed -$288K
PG icon
82
Procter & Gamble
PG
$341B
-2,009
Closed -$251K
QSR icon
83
Restaurant Brands International
QSR
$25.8B
-35,300
Closed -$326K
SDY icon
84
State Street SPDR S&P Dividend ETF
SDY
$23.8B
-2,735
Closed -$295K
VIS icon
85
Vanguard Industrials ETF
VIS
$8.42B
-1,586
Closed -$245K
VNQ icon
86
Vanguard Real Estate ETF
VNQ
$39.2B
-17,704
Closed -$1.64M
VO icon
87
Vanguard Morningstar Mid-Cap ETF
VO
$109B
-8,164
Closed -$364K

Similar funds

Towercrest Capital Management's Q1 2020 Portfolio in Review

As of Q1 2020, Towercrest Capital Management held 87 positions worth $333M, down 15% from $391M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Towercrest Capital Management's Q1 2020 filing shows 8 new, 31 increased, 31 reduced and 9 closed positions. Its largest new stake was Iovance Biotherapeutics: 25,000 shares worth $748K. The largest sale was iShares Floating Rate Bond ETF, an estimated $5.35M.

By sector, the portfolio is most concentrated in Technology at 1.8% of assets, up from 1.5% a quarter earlier, followed by Financials and Healthcare.

  • Towercrest Capital Management's largest Q1 2020 buy was Iovance Biotherapeutics: 25,000 shares worth $748K.
  • Towercrest Capital Management added most to State Street SPDR Portfolio Developed World ex-US ETF in Q1 2020, an estimated $3.47M increase.
  • Towercrest Capital Management's biggest Q1 2020 reduction was iShares Floating Rate Bond ETF, cutting an estimated $5.35M.
  • Towercrest Capital Management fully exited Vanguard Real Estate ETF in Q1 2020, selling an estimated $1.64M.
  • Towercrest Capital Management's ten largest holdings make up 50% of its $333M portfolio in Q1 2020.
  • Towercrest Capital Management opened 8 new positions and closed 9 in Q1 2020.
  • Towercrest Capital Management's portfolio value fell 15% quarter-over-quarter to $333M.

Based on Towercrest Capital Management's 13F filing for Q1 2020, filed 14 May 2020.